ISRCTN88345833已完成不适用
A comparison of treosulfan and carboplatin in patients with ovarian cancer not suitable for treatment with cisplati
Cancer Research UK (CRUK) (UK)0 个研究点目标入组 0 人开始时间: 2001年7月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Not considered for cisplatin =75 mg/m2
- •2. Stages Ic-IV
- •3. Histologically proven epithelial ovarian cancer
- •4. Life expectancy .3 months
- •5. World Health Organisation (WHO) Performance status 0-3
- •6. Creatinine clearance =20 ml/min White Blood Cell (WBC) Count =3.5 x 10^9/l Platelets =100 x 10^9/l
排除标准
- •Not provided at time of registration
研究者
相似试验
已完成
不适用
A Phase I/II Study of Carboplatin and TS-1 in Patients with Advanced Non-small Cell Lung Cancer: CJLSG-0402Advanced non-small cell lung cancerJPRN-C000000234Central Japan Lung Study Group32
已完成
不适用
The combination chemotherapy of carboplatin and TS-1 followed by the maintenance therapy of TS-1 in advanced non-small cell lung cancer. Phase 2 trial.JPRN-UMIN000025932niversity of Fukui25
未知
不适用
Phase I–II study of TS-1 and Carboplatin in advanced Non Small Lung Cancernon small cell lung cancerJPRN-C000000054Department of Medical Oncology, Kinki University School of Medicine25
已完成
不适用
Phase 1 study of cisplatin + sulfasalazine in patients with advanced gastric cancer.advanced gastric cancerJPRN-UMIN000015595ational Cancer Center Hospital East18
已完成
3 期
A phase III study comparing carboplatin plus pemetrexed followed by maintenance pemetrexed with docetaxel in elderly patients with advanced non-squamous non-small-cell lung cancer (JCOG1210/WJOG7813L CBDCA/PEM vs DOC Phase III)Elderly patients with advanced non-squamous non-small-cell lung cancerJPRN-UMIN000011460Japan Clinical Oncology Group (JCOG)430